Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study65

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study11

Views

Views
October 20251
November 20250
December 20252
January 20260
February 20260
March 20262
April 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Argentina1
Australia1
Brazil1
Germany1
Finland1
Netherlands1
Romania1
 

Top cities views

Views
Los Angeles2
Ashburn1
Frankfurt am Main1
Helsinki1
Nueve de Julio1
Tilburg1
Torres1